Skip to main content
Fig. 5 | World Journal of Surgical Oncology

Fig. 5

From: N6-methyladenosine (m6A) RNA methylation regulator SNRPC is a prognostic biomarker and is correlated with immunotherapy in hepatocellular carcinoma

Fig. 5

A Abundance of TME cells between the high- and low-SNRPC groups calculated by MCP-counter. B Box plot showing the proportion of TME cells between the high- and low-SNRPC groups analyzed by MCP-counter. C, D Heat map and box plot showing the infiltration of immune cells between the high- and low-SNRPC groups calculated by ssGSEA

Back to article page